Novel regulation of Smad3 oligomerization and DNA binding by its linker domain
- PMID: 19645436
- DOI: 10.1021/bi9005489
Novel regulation of Smad3 oligomerization and DNA binding by its linker domain
Abstract
Smad proteins are key effectors of the transforming growth factor beta (TGFbeta) signaling pathway in mammalian cells. Smads are composed of two highly structured and conserved domains called Mad homology 1 (MH1) and 2 (MH2), which are linked together by a nonconserved linker region. The recent identification of phosphorylation sites and binding sites for ubiquitin ligases in the linker regions of TGFbeta and bone morphogenetic protein (BMP) receptor-regulated Smads suggested that the linker may contribute to the regulation of Smad function by facilitating cross-talks with other signaling pathways. In the present study, we have generated and characterized novel Smad3 mutants bearing individual substitutions of conserved and nonconserved amino acid residues within a previously described transcriptionally active linker fragment. Our analysis showed that the conserved linker amino acids glutamine 222 and proline 229 play important roles in Smad functions such as homo- and hetero-oligomerization, nuclear accumulation in response to TGFbeta stimulation, and DNA binding. Furthermore, a Smad3 mutant bearing a substitution of the nonconserved amino acid asparagine 218 to alanine displayed enhanced transactivation potential relative to wild type Smad3. Finally, Smad3 P229A inhibited TGFbeta signaling when overexpressed in mammalian cells. In conclusion, our data are in line with previous studies supporting an important regulatory role of the linker region of Smads in their function as key transducers of TGFbeta signaling.
Similar articles
-
Novel mutations in Smad proteins that inhibit signaling by the transforming growth factor beta in mammalian cells.Biochemistry. 2007 Dec 4;46(48):13775-86. doi: 10.1021/bi701540u. Epub 2007 Nov 10. Biochemistry. 2007. PMID: 17994767
-
Modeling and analysis of MH1 domain of Smads and their interaction with promoter DNA sequence motif.J Mol Graph Model. 2009 Apr;27(7):803-12. doi: 10.1016/j.jmgm.2008.12.003. Epub 2008 Dec 24. J Mol Graph Model. 2009. PMID: 19157940
-
Roles for lysine residues of the MH2 domain of Smad3 in transforming growth factor-beta signaling.FEBS Lett. 2005 May 23;579(13):2853-62. doi: 10.1016/j.febslet.2005.04.023. Epub 2005 Apr 26. FEBS Lett. 2005. PMID: 15907489
-
Regulation of the TGFbeta signalling pathway by ubiquitin-mediated degradation.Oncogene. 2004 Mar 15;23(11):2071-8. doi: 10.1038/sj.onc.1207412. Oncogene. 2004. PMID: 15021894 Review.
-
RNF11 is a multifunctional modulator of growth factor receptor signalling and transcriptional regulation.Eur J Cancer. 2005 Nov;41(16):2549-60. doi: 10.1016/j.ejca.2005.08.020. Epub 2005 Oct 13. Eur J Cancer. 2005. PMID: 16226459 Review.
Cited by
-
Smad phosphoisoform signaling specificity: the right place at the right time.Carcinogenesis. 2011 Nov;32(11):1578-88. doi: 10.1093/carcin/bgr172. Epub 2011 Jul 27. Carcinogenesis. 2011. PMID: 21798854 Free PMC article. Review.
-
Structure, function, and tethering of DNA-binding domains in σ⁵⁴ transcriptional activators.Biopolymers. 2013 Dec;99(12):1082-96. doi: 10.1002/bip.22333. Biopolymers. 2013. PMID: 23818155 Free PMC article.
-
Smad3 Phospho-Isoform Signaling in Nonalcoholic Steatohepatitis.Int J Mol Sci. 2022 Jun 3;23(11):6270. doi: 10.3390/ijms23116270. Int J Mol Sci. 2022. PMID: 35682957 Free PMC article. Review.
-
Role of transforming growth factor Beta in corneal function, biology and pathology.Curr Mol Med. 2010 Aug;10(6):565-78. doi: 10.2174/1566524011009060565. Curr Mol Med. 2010. PMID: 20642439 Free PMC article. Review.
-
Smad3 phospho-isoform signaling in hepatitis C virus-related chronic liver diseases.World J Gastroenterol. 2014 Sep 21;20(35):12381-90. doi: 10.3748/wjg.v20.i35.12381. World J Gastroenterol. 2014. PMID: 25253939 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources